These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6616470)
1. Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression. Huseby RA Cancer Res; 1983 Nov; 43(11):5365-78. PubMed ID: 6616470 [TBL] [Abstract][Full Text] [Related]
2. Changes in fine structure accompanying estrogen-induced tumorigenesis of Leydig cells in the mouse testis. Kurland G; Christensen AK; Huseby RA Cancer Res; 1975 Jul; 35(7):1671-86. PubMed ID: 236824 [TBL] [Abstract][Full Text] [Related]
3. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice. Huseby RA; Page RH Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521 [TBL] [Abstract][Full Text] [Related]
4. Effects of tamoxifen on estrogen-induced enhancement or inhibition of tumor growth in mouse Leydig cell tumor lines. Sato B; Maeda Y; Nishizawa Y; Noma K; Kishimoto S; Matsumoto K Cancer Res; 1984 Oct; 44(10):4386-91. PubMed ID: 6467199 [TBL] [Abstract][Full Text] [Related]
5. Estrogen-induced Leydig cell tumor in the mouse: a model system for the study of carcinogenesis and hormone dependency. Huseby RA J Toxicol Environ Health Suppl; 1976; 1():177-92. PubMed ID: 11351 [TBL] [Abstract][Full Text] [Related]
6. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors. Navickis RJ; Shimkin MB; Hsueh AJ Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor. Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850 [TBL] [Abstract][Full Text] [Related]
8. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia. Juriansz RL; Huseby RA; Wilcox RB Cancer Res; 1988 Jan; 48(1):14-8. PubMed ID: 3334987 [TBL] [Abstract][Full Text] [Related]
9. DNA synthesis and DNA polymerase activity in Leydig cells of diethylstilbestrol-stimulated mouse testes. Spruance SL; Wilcox B; Richards OC; Foster DN; Huseby RA; Samuels LT Cancer Res; 1978 Feb; 38(2):424-30. PubMed ID: 620411 [TBL] [Abstract][Full Text] [Related]
10. Effects of estrogen and tamoxifen on secretory glycoprotein synthesis in mouse Leydig cell tumor in vivo. Nishizawa Y; Sato B; Kishimoto S; Matsumoto K Anticancer Res; 1988; 8(4):557-62. PubMed ID: 3178148 [TBL] [Abstract][Full Text] [Related]
11. Stimulation by estrogen and progesterone of the in vivo growth of transformed murine Leydig cells only at the limited early phase of growth. Yamamoto T; Li I; Uchida N; Nishizawa Y; Yamamoto R; Terada N; Taniguchi H; Matsumoto K; Sato B Anticancer Res; 1992; 12(5):1339-45. PubMed ID: 1444190 [TBL] [Abstract][Full Text] [Related]
13. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors. Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624 [TBL] [Abstract][Full Text] [Related]
14. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
16. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation. Gattelli A; Cirio MC; Quaglino A; Schere-Levy C; Martinez N; Binaghi M; Meiss RP; Castilla LH; Kordon EC Cancer Res; 2004 Aug; 64(15):5193-9. PubMed ID: 15289324 [TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Nitrofurazone (CAS No. 59-87-0) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1988 Jun; 337():1-183. PubMed ID: 12732899 [TBL] [Abstract][Full Text] [Related]
19. A classification of transplantable tumors in Nb rats controlled by estrogen from dormancy to autonomy. Noble RL; Hoover L Cancer Res; 1975 Nov; 35(11 Pt 1):2935-41. PubMed ID: 1182686 [TBL] [Abstract][Full Text] [Related]
20. Effects of cryptorchidy, parabiosis, and estrogen administration upon Leydig cell tumorigenesis in Fischer rats. Huseby RA Cancer Res; 1981 Aug; 41(8):3172-8. PubMed ID: 6113890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]